{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:53:56Z","timestamp":1782773636527,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Psoriasis is a chronic, autoimmune, papulosquamous skin disorder, characterized by the formation of drop-like papules and silvery-white plaques surrounded by reddened or inflamed skin, existing predominantly on the scalp, knees and elbows. The characteristic inflammation and hyperproliferation of keratinocytes in psoriasis is regulated by progranulin (PGRN), which suppresses the expression and release of inflammatory cytokines, such as TNF-\u03b1.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methodology<\/jats:title>\n                <jats:p>In this study mutation analysis of the <jats:italic>PGRN<\/jats:italic> gene was performed by extracting the genomic DNA from blood samples of 171 diagnosed psoriasis patients and controls through standard salting-out method, followed by amplification and sequencing of the targeted region of exon 5\u20137 of <jats:italic>PGRN<\/jats:italic> gene.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Three single nucleotide polymorphisms, rs25646, rs850713 and a novel point mutation 805A\/G were identified in the <jats:italic>PGRN<\/jats:italic> gene with significant association with the disease. The variant alleles of the polymorphisms were significantly distributed among cases and controls, and statistical analysis suggested that the mutant genotypes conferred a higher risk of psoriasis development and progression. Multi-SNP haplotype analysis indicated that the CAA (OR\u2009=\u20098.085, 95% CI\u2009=\u20095.16\u201312.66) and the CAG (OR\u2009=\u20093.204, 95% CI\u2009=\u20091.97\u20135.21) haplotypes were significantly associated with psoriasis pathogenesis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings demonstrate that polymorphisms in <jats:italic>PGRN<\/jats:italic> might act as potential molecular targets for early diagnosis of psoriasis in susceptible individuals.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-023-01757-8","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T22:02:10Z","timestamp":1703196130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mutations in PGRN gene associated with the risk of psoriasis in Pakistan: a case control study"],"prefix":"10.1186","volume":"16","author":[{"given":"Saima","family":"Saleem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunaira","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Samdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Khoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitwat","family":"Zehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"1757_CR1","volume-title":"Global Report on Psoriasis","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Global Report on Psoriasis. 2018. Retrieved from:https:\/\/apps.who.int\/10665\/204417\/9789241565189_eng.pdf.psoriasis?sequence=1."},{"key":"1757_CR2","first-page":"97","volume":"93","author":"F Gr\u00e4n","year":"2020","unstructured":"Gr\u00e4n F, Kerstan A, Serfling E, Goebeler M, Muhammad K. Focus: skin: current developments in the immunology of psoriasis. Yale J Biol Med. 2020;93:97\u2013110 PMID: 32226340.","journal-title":"Yale J Biol Med."},{"key":"1757_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370:263\u201371. https:\/\/doi.org\/10.1016\/S0140-6736(07)61128-3.","journal-title":"Lancet."},{"key":"1757_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.mpmed.2021.03.005","volume":"49","author":"E Higgins","year":"2021","unstructured":"Higgins E. Psoriasis. Medicine. 2021;49:361\u20139. https:\/\/doi.org\/10.1016\/j.mpmed.2021.03.005.","journal-title":"Medicine."},{"key":"1757_CR5","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.3390\/ijms18122684","volume":"18","author":"Y Woo","year":"2017","unstructured":"Woo Y, Cho D, Park H. Molecular mechanisms and management of a cutaneous inflammatory disorder: psoriasis. Int J Mol Sci. 2017;18:2684\u2013710. https:\/\/doi.org\/10.3390\/ijms18122684.","journal-title":"Int J Mol Sci."},{"key":"1757_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2147\/PTT.S64950","volume":"6","author":"N Ayala-Font\u00e1nez","year":"2016","unstructured":"Ayala-Font\u00e1nez N, Soler DC, McCormick TS. Current knowledge on psoriasis and autoimmune diseases. Psoriasis. 2016;6:7\u201332. https:\/\/doi.org\/10.2147\/PTT.S64950.","journal-title":"Psoriasis."},{"key":"1757_CR7","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.3390\/ijms20184347","volume":"20","author":"K Kamiya","year":"2019","unstructured":"Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci. 2019;20:4347\u201361. https:\/\/doi.org\/10.3390\/ijms20184347.","journal-title":"Int J Mol Sci."},{"key":"1757_CR8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/1346-8138.13806","volume":"44","author":"J Zeng","year":"2017","unstructured":"Zeng J, Luo S, Huang Y, Lu Q. Critical role of environmental factors in the pathogenesis of psoriasis. J Dermatol. 2017;44:863\u201372. https:\/\/doi.org\/10.1111\/1346-8138.13806.","journal-title":"J Dermatol."},{"key":"1757_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5772\/intechopen.68344","volume":"1","author":"HM Merve","year":"2017","unstructured":"Merve HM, Sevilay K, Sibel O, Ba\u015fak B, Ceren CG, Demirci T, C\u00fcneyt A. Psoriasis and genetics. Interdiscip Approach Psoriasis. 2017;1:1\u201312. https:\/\/doi.org\/10.5772\/intechopen.68344.","journal-title":"Interdiscip Approach Psoriasis."},{"key":"1757_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/ijms19010179","volume":"19","author":"A Chiricozzi","year":"2018","unstructured":"Chiricozzi A, Romanelli P, Volpe E, Borsellino G, Romanelli M. Scanning the immunopathogenesis of psoriasis. Int J Mol Sci. 2018;19:179\u2013210. https:\/\/doi.org\/10.3390\/ijms19010179.","journal-title":"Int J Mol Sci."},{"key":"1757_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/978-3-319-29785-9_21","volume":"21","author":"P Di Meglio","year":"2017","unstructured":"Di Meglio P, Nestle FO. Immunopathogenesis of psoriasis. Clin Basic Immunodermatol. 2017;21:373\u201395. https:\/\/doi.org\/10.1007\/978-3-319-29785-9_21.","journal-title":"Clin Basic Immunodermatol."},{"key":"1757_CR12","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3390\/genes11101155","volume":"11","author":"G Rioux","year":"2020","unstructured":"Rioux G, Ridha Z, Simard M, Turgeon F, Gu\u00e9rin FL, Pouliot R. Transcriptome profiling analyses in psoriasis: a dynamic contribution of keratinocytes to the pathogenesis. Genes. 2020;11:1155\u201377. https:\/\/doi.org\/10.3390\/genes11101155.","journal-title":"Genes."},{"key":"1757_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/imm.12446","volume":"145","author":"K Huang","year":"2015","unstructured":"Huang K, Chen A, Zhang X, Song Z, Xu H, Cao J, Yin Y. Progranulin is preferentially expressed in patients with psoriasis vulgaris and protects mice from psoriasis-like skin inflammation. Immunology. 2015;145:279\u201387. https:\/\/doi.org\/10.1111\/imm.12446.","journal-title":"Immunology."},{"key":"1757_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","volume":"69","author":"AM Goldminz","year":"2013","unstructured":"Goldminz AM, Au SC, Kim N, Gottlieb AB, Lizzul PF. NF-\u03baB: an essential transcription factor in psoriasis. J Dermatol Sci. 2013;69:89\u201394. https:\/\/doi.org\/10.1016\/j.jdermsci.2012.11.002.","journal-title":"J Dermatol Sci."},{"key":"1757_CR15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/1346-8138.14139","volume":"45","author":"E Ogawa","year":"2018","unstructured":"Ogawa E, Sato Y, Minagawa A, Okuyama R. Pathogenesis of psoriasis and development of treatment. J Dermatol. 2018;45:264\u201372. https:\/\/doi.org\/10.1111\/1346-8138.14139.","journal-title":"J Dermatol."},{"key":"1757_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/B978-0-12-386456-7.01804-9","volume-title":"Reference module in biomedical sciences: pathobiology of human disease","author":"TJ Sellati","year":"2014","unstructured":"Sellati TJ, Sahay B. Cells of innate immunity: mechanisms of activation. In: McManus LM, Mitchell RN, editors. Reference module in biomedical sciences: pathobiology of human disease. Academic Press; 2014. p. 258\u201374. https:\/\/doi.org\/10.1016\/B978-0-12-386456-7.01804-9."},{"key":"1757_CR17","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.drudis.2017.06.006","volume":"22","author":"V Abella","year":"2017","unstructured":"Abella V, Pino J, Scotece M, Conde J, Lago F, Gonzalez-Gay MA, Mera A, G\u00f3mez R, Mobasheri A, Gualillo O. Progranulin as a biomarker and potential therapeutic agent. Drug Discov Today. 2017;22:1557\u201364. https:\/\/doi.org\/10.1016\/j.drudis.2017.06.006.","journal-title":"Drug Discov Today."},{"key":"1757_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-10-105","volume":"10","author":"Y Egashira","year":"2013","unstructured":"Egashira Y, Suzuki Y, Azuma Y, Takagi T, Mishiro K, Sugitani S, Hara H. The growth factor progranulin attenuates neuronal injury induced by cerebral ischemia-reperfusion through the suppression of neutrophil recruitment. J Neuroinflammation. 2013;10:1\u201313. https:\/\/doi.org\/10.1186\/1742-2094-10-105.","journal-title":"J Neuroinflammation."},{"key":"1757_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ebiom.2016.08.004","volume":"11","author":"J Jian","year":"2016","unstructured":"Jian J, Zhao S, Tian QY, Liu H, Zhao Y, Chen WC, Grunig G, Torres PA, Wang BC, Zeng B, Pastores G, Liu CJ. Association between progranulin and Gaucher disease. EBioMedicine. 2016;11:127\u201337. https:\/\/doi.org\/10.1016\/j.ebiom.2016.08.004.","journal-title":"EBioMedicine."},{"key":"1757_CR20","doi-asserted-by":"publisher","first-page":"6543","DOI":"10.2147\/JIR.S339254","volume":"14","author":"YJ Lan","year":"2021","unstructured":"Lan YJ, Sam NB, Cheng MN, Pan HF, Gao J. Progranulin as a potential therapeutic target in immune-mediated diseases. J Inflamm Res. 2021;14:6543\u201356. https:\/\/doi.org\/10.2147\/JIR.S339254.","journal-title":"J Inflamm Res."},{"key":"1757_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2174\/1871523018666190724124214","volume":"19","author":"C Liu","year":"2020","unstructured":"Liu C, Li J, Shi W, Zhang L, Liu S, Lian Y, Liang S, Wang H. Progranulin regulates inflammation and tumor. Anti-Inflamm Anti-Allergy Agents Med Chem. 2020;19:88\u2013102. https:\/\/doi.org\/10.2174\/1871523018666190724124214.","journal-title":"Anti-Inflamm Anti-Allergy Agents Med Chem."},{"key":"1757_CR22","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1126\/science.1199214","volume":"332","author":"W Tang","year":"2011","unstructured":"Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, Liu GY, Liu CJ. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science. 2011;332:478\u201384. https:\/\/doi.org\/10.1126\/science.1199214.","journal-title":"Science."},{"key":"1757_CR23","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1111\/jocd.12966","volume":"18","author":"AGA Farag","year":"2019","unstructured":"Farag AGA, Shoaib MA, Samaka RM, Abdou AG, Mandour MM, Ibrahim RAL. Progranulin and beta-catenin in psoriasis: an immunohistochemical study. J Cosmet Dermatol. 2019;18:2019\u201326. https:\/\/doi.org\/10.1111\/jocd.12966.","journal-title":"J Cosmet Dermatol."},{"key":"1757_CR24","doi-asserted-by":"publisher","unstructured":"Bateman A, Cheung ST, Bennett HP. A brief overview of progranulin in health and disease. Progranulin. 2018;3-15 https:\/\/doi.org\/10.1007\/978-1-4939-8559-3_1.","DOI":"10.1007\/978-1-4939-8559-3_1"},{"key":"1757_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00296-017-3899-7","volume":"38","author":"N Hu","year":"2018","unstructured":"Hu N, Cui Y, Yang Q, Wang L, Yang X, Xu H. Association of polymorphisms in TNF and GRN genes with ankylosing spondylitis in a Chinese Han population. Rheumatol Int. 2018;38:481\u20137. https:\/\/doi.org\/10.1007\/s00296-017-3899-7.","journal-title":"Rheumatol Int."},{"key":"1757_CR26","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","volume":"140","author":"JE Hawkes","year":"2017","unstructured":"Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol. 2017;140:645\u201353. https:\/\/doi.org\/10.1016\/j.jaci.2017.07.004.","journal-title":"J Allergy Clin Immunol."},{"key":"1757_CR27","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20:1475. https:\/\/doi.org\/10.3390\/ijms20061475.","journal-title":"Int J Mol Sci."},{"key":"1757_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.clim.2011.09.005","volume":"141","author":"PP Sfikakis","year":"2011","unstructured":"Sfikakis PP, Tsokos GC. Towards the next generation of anti-TNF drugs. Clin Immunol. 2011;141:231\u20135. https:\/\/doi.org\/10.1016\/j.clim.2011.09.005.","journal-title":"Clin Immunol."},{"key":"1757_CR29","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"S MWer","year":"1988","unstructured":"MWer S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215. https:\/\/doi.org\/10.1093\/nar\/16.3.1215.","journal-title":"Nucleic Acids Res."},{"key":"1757_CR30","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s10753-016-0370-y","volume":"39","author":"R Tian","year":"2016","unstructured":"Tian R, Li Y, Yao X. PGRN suppresses inflammation and promotes autophagy in keratinocytes through the Wnt\/\u03b2-catenin signaling pathway. Inflammation. 2016;39:1387\u201394. https:\/\/doi.org\/10.1007\/s10753-016-0370-y.","journal-title":"Inflammation."},{"key":"1757_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2019.00914","volume":"10","author":"Z Zeng","year":"2019","unstructured":"Zeng Z, Bromberg Y. Predicting functional effects of synonymous variants: a systematic review and perspectives. Front Genet. 2019;10:1\u201315. https:\/\/doi.org\/10.3389\/fgene.2019.00914.","journal-title":"Front Genet."},{"key":"1757_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-7364-4-5-284","volume":"4","author":"DN Cooper","year":"2010","unstructured":"Cooper DN. Functional intronic polymorphisms: buried treasure awaiting discovery within our genes. Hum Genomics. 2010;4:1\u20135. https:\/\/doi.org\/10.1186\/1479-7364-4-5-284.","journal-title":"Hum Genomics."},{"key":"1757_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4406","volume":"15","author":"L Thurner","year":"2013","unstructured":"Thurner L, Zaks M, Preuss KD, Fadle N, Regitz E, Ong MF, Pfreundschuh M, Assmann G. Progranulin antibodies entertain a proinflammatory environment in a subgroup of patients with psoriatic arthritis. Arthritis Res Ther. 2013;15:1\u20139. https:\/\/doi.org\/10.1186\/ar4406.","journal-title":"Arthritis Res Ther."},{"key":"1757_CR34","doi-asserted-by":"publisher","first-page":"215e1","DOI":"10.1016\/j.neurobiolaging.2015.10.029","volume":"38","author":"CM Karch","year":"2016","unstructured":"Karch CM, Ezerskiy L, Redaelli V, Giovagnoli AR, Tiraboschi P, Pelliccioni G, Pelliccioni P, Kapetis D, D\u2019Amato I, Piccoli E, Ferretti MG, Rossi G. Missense mutations in progranulin gene associated with frontotemporal lobar degeneration: study of pathogenetic features. Neurobiol Aging. 2016;38:215e1-21e12. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.10.029.","journal-title":"Neurobiol Aging."},{"key":"1757_CR35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3233\/jad-2009-1170","volume":"18","author":"C Fenoglio","year":"2009","unstructured":"Fenoglio C, Galimberti D, Cortini F, Kauwe JS, Cruchaga C, Venturelli E, Scarpini E. rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer\u2019s disease. J Alzheimers Dis. 2009;18:603\u201312. https:\/\/doi.org\/10.3233\/jad-2009-1170.","journal-title":"J Alzheimers Dis."}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01757-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01757-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01757-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T22:02:15Z","timestamp":1703196135000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01757-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1757"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01757-8","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]},"assertion":[{"value":"18 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed written consent to participate was taken from all participants to participate in the study. The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki and all procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional review board of The Karachi Institute of Biotechnology and Genetic Engineering (KIBGE) and Jinnah Post Graduate Medical Centre (JPMC) (Ref No.F.2\u201381\/2021-GENL\/58186\/JPMC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"335"}}